Free Trial

The Cigna Group (CI) Stock Forecast & Price Target

The Cigna Group logo
$321.52 -2.36 (-0.73%)
(As of 11/15/2024 ET)

The Cigna Group - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
14

Based on 15 Wall Street analysts who have issued ratings for The Cigna Group in the last 12 months, the stock has a consensus rating of "Buy." Out of the 15 analysts, 1 has given a hold rating, 13 have given a buy rating, and 1 has given a strong buy rating for CI.

Consensus Price Target

$394.64
22.74% Upside
According to the 15 analysts' twelve-month price targets for The Cigna Group, the average price target is $394.64. The highest price target for CI is $438.00, while the lowest price target for CI is $348.00. The average price target represents a forecasted upside of 22.74% from the current price of $321.52.

CI Analyst Ratings Over Time

TypeCurrent Forecast
11/17/23 to 11/16/24
1 Month Ago
10/18/23 to 10/17/24
3 Months Ago
8/19/23 to 8/18/24
1 Year Ago
11/17/22 to 11/17/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
13 Buy rating(s)
13 Buy rating(s)
13 Buy rating(s)
5 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$394.64$392.79$384.64$336.40
Forecasted Upside22.74% Upside11.23% Upside12.36% Upside19.05% Upside
Consensus Rating
Buy
Buy
Buy
Moderate Buy

CI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

The Cigna Group Stock vs. The Competition

TypeThe Cigna GroupMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.80
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside22.74% Upside28,534.42% Upside9.87% Upside
News Sentiment Rating
Positive News

See Recent CI News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/5/2024Piper Sandler
2 of 5 stars
 Reiterated RatingOverweight ➝ Overweight$392.00 ➝ $394.00+25.49%
11/5/2024Barclays
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$405.00 ➝ $420.00+34.48%
11/4/2024Deutsche Bank Aktiengesellschaft
3 of 5 stars
 Lower TargetBuy ➝ Buy$398.00 ➝ $394.00+25.93%
11/1/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$410.00 ➝ $410.00+29.68%
11/1/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$384.00 ➝ $377.00+19.61%
10/23/2024Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$400.00 ➝ $400.00+25.98%
Shocking footage from Bill Gates’ $100,000,000,000 AI Bet (Ad)

If you missed out on Nvidia, watch this BEFORE November 19th.

9/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$402.00 ➝ $422.00+16.25%
8/21/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$435.00 ➝ $438.00+27.49%
5/30/2024Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/30/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$388.00+16.54%
5/3/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$370.00 ➝ $400.00+18.29%
3/4/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$382.00 ➝ $392.00+16.52%
2/6/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$334.00 ➝ $348.00+6.18%
2/5/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$360.00 ➝ $370.00+14.41%
1/4/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$330.00 ➝ $372.00+22.53%
8/17/2023Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
8/7/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy ➝ Strong-Buy$310.00 ➝ $330.00+15.15%
8/4/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$320.00 ➝ $350.00+21.48%
6/20/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$375.00 ➝ $365.00+35.77%
2/8/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$335.00 ➝ $309.00+6.92%
2/8/2023Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$309.00 ➝ $335.00+15.92%
2/6/2023Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$350.00 ➝ $320.00+9.35%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:57 PM ET.


Should I Buy The Cigna Group Stock? CI Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, October 30, 2024. Please send any questions or comments about these The Cigna Group pros and cons to contact@marketbeat.com.

The Cigna Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in The Cigna Group:

  • The Cigna Group stock has shown consistent growth, with a 1-year high of $370.83, indicating potential for capital appreciation.
  • Institutional investors, such as Silicon Valley Capital Partners and Cedar Wealth Management LLC, have been increasing their stakes in The Cigna Group, reflecting confidence in the company's future performance.
  • Analysts have given The Cigna Group a consensus rating of "Buy" with a target price of $392.79, suggesting further upside potential.
  • The company reported strong quarterly earnings results, beating analysts' estimates with a revenue increase of 24.6% year-over-year, indicating a healthy financial performance.
  • The Cigna Group pays a quarterly dividend with a dividend yield of 1.64%, providing investors with a steady income stream.

The Cigna Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in The Cigna Group for these reasons:

  • The stock's current price of $348.10 is below its 1-year high, suggesting potential volatility in the short term.

CI Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for The Cigna Group is $394.64, with a high forecast of $438.00 and a low forecast of $348.00.

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for The Cigna Group in the last twelve months. There is currently 1 hold rating, 13 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CI shares.

According to analysts, The Cigna Group's stock has a predicted upside of 22.74% based on their 12-month stock forecasts.

The Cigna Group has been rated by research analysts at Barclays, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, JPMorgan Chase & Co., Piper Sandler, Royal Bank of Canada, and Stephens in the past 90 days.

Analysts like The Cigna Group more than other "medical" companies. The consensus rating for The Cigna Group is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CI compares to other companies.


This page (NYSE:CI) was last updated on 11/16/2024 by MarketBeat.com Staff
From Our Partners